Q1 EPS Estimate for Phibro Animal Health Raised by Analyst

Phibro Animal Health Co. (NASDAQ:PAHC) – Zacks Research upped their Q1 2027 earnings estimates for Phibro Animal Health in a research report issued to clients and investors on Tuesday, January 7th. Zacks Research analyst R. Department now expects that the company will post earnings of $0.49 per share for the quarter, up from their prior estimate of $0.47. The consensus estimate for Phibro Animal Health’s current full-year earnings is $1.62 per share. Zacks Research also issued estimates for Phibro Animal Health’s Q2 2027 earnings at $0.53 EPS.

Several other analysts have also issued reports on PAHC. Barclays increased their target price on Phibro Animal Health from $13.00 to $20.00 and gave the stock an “underweight” rating in a report on Tuesday, November 12th. StockNews.com raised shares of Phibro Animal Health from a “buy” rating to a “strong-buy” rating in a report on Saturday, January 4th. Finally, Morgan Stanley increased their price target on shares of Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a research report on Tuesday, December 17th. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $20.50.

Phibro Animal Health Trading Down 6.7 %

Shares of NASDAQ:PAHC opened at $20.05 on Friday. The company has a market capitalization of $812.09 million, a P/E ratio of 46.63, a P/E/G ratio of 0.58 and a beta of 0.53. The company has a debt-to-equity ratio of 1.81, a current ratio of 3.23 and a quick ratio of 1.69. The business’s 50 day simple moving average is $22.75 and its 200 day simple moving average is $21.08. Phibro Animal Health has a 1 year low of $10.03 and a 1 year high of $25.98.

Hedge Funds Weigh In On Phibro Animal Health

Several institutional investors and hedge funds have recently added to or reduced their stakes in PAHC. Quantbot Technologies LP acquired a new position in shares of Phibro Animal Health during the third quarter worth $70,000. nVerses Capital LLC acquired a new position in Phibro Animal Health in the 3rd quarter worth about $70,000. China Universal Asset Management Co. Ltd. raised its position in Phibro Animal Health by 63.7% in the third quarter. China Universal Asset Management Co. Ltd. now owns 3,912 shares of the company’s stock valued at $88,000 after purchasing an additional 1,522 shares during the last quarter. CWM LLC boosted its stake in shares of Phibro Animal Health by 190.8% during the third quarter. CWM LLC now owns 6,363 shares of the company’s stock valued at $143,000 after purchasing an additional 4,175 shares in the last quarter. Finally, Algert Global LLC bought a new stake in shares of Phibro Animal Health during the second quarter worth about $193,000. Institutional investors own 99.34% of the company’s stock.

Phibro Animal Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, December 18th. Investors of record on Wednesday, November 27th were issued a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a dividend yield of 2.39%. The ex-dividend date was Wednesday, November 27th. Phibro Animal Health’s dividend payout ratio (DPR) is presently 111.63%.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.